Abstract:Objective: The objective of this study was to identify the risk factors that influence metastasis and prognosis in patients with nodular melanoma (NM), as well as to develop and validate a prognostic model using artificial intelligence (AI) algorithms. Methods: The Surveillance, Epidemiology, and End Results (SEER) database was queried for 4,727 patients with NM based on the inclusion/exclusion criteria. Their clinicopathological characteristics were retrospectively reviewed, and logistic regression analysis was utilized to identify risk factors for metastasis. This was followed by employing Multilayer Perceptron (MLP), Adaptive Boosting (AB), Bagging (BAG), logistic regression (LR), Gradient Boosting Machine (GBM), and eXtreme Gradient Boosting (XGB) algorithms to develop metastasis models. The performance of the six models was evaluated and compared, leading to the selection and visualization of the optimal model. Through integrating the prognostic factors of Cox regression analysis with the optimal models, the prognostic prediction model was constructed, validated, and assessed. Results: Logistic regression analyses identified that marital status, gender, primary site, surgery, radiation, chemotherapy, system management, and N stage were all independent risk factors for NM metastasis. MLP emerged as the optimal model among the six models (AUC = 0.932, F1 = 0.855, Accuracy = 0.856, Sensitivity = 0.878), and the corresponding network calculator (https://shimunana-nm-distant-m-nm-m-distant-8z8k54.streamlit.app/) was developed. The following were examined as independent prognostic factors: MLP, age, marital status, sequence number, laterality, surgery, radiation, chemotherapy, system management, T stage, and N stage. System management and surgery emerged as protective factors (HR < 1). To predict 1-, 3-, and 5-year overall survival (OS), a nomogram was created. The validation results demonstrated that the model exhibited good discrimination and consistency, as well as high clinical usefulness. Conclusion: The developed prediction model more effectively reflects the prognosis of patients with NM and differentiates between the risk level of patients, serving as a useful supplement to the classical American Joint Committee on Cancer (AJCC) staging system and offering a reference for clinically stratified individualized treatment and prognosis prediction. Furthermore, the model enables clinicians to quantify the risk of metastasis in NM patients, assess patient survival, and administer precise treatments.

An adaptive treatment recommendation and outcome prediction model for metastatic melanoma

Artificial intelligence-assisted metastasis and prognosis model for patients with nodular melanoma

Evaluation of Machine Learning Algorithms for the Prognosis of Breast Cancer from the Surveillance, Epidemiology, and End Results Database

Identification and Validation of Three Risk Models in Skin Melanoma Based on Bioinformatics Analysis

The Prognostic Landscape of Adaptive Immune Resistance Signatures and Infiltrating Immune Cells in the Tumor Microenvironment of Uveal Melanoma.

A Novel Nomogram and Risk Classification System Predicting the Cancer-Specific Mortality of Patients with Initially Diagnosed Metastatic Cutaneous Melanoma

Predictive and on-treatment monitoring biomarkers in advanced melanoma: Moving toward personalized medicine

Medical decision support system for cancer treatment in precision medicine in developing countries

Individualized melanoma risk prediction using machine learning with electronic health records

A novel risk model based on anoikis: Predicting prognosis and immune infiltration in cutaneous melanoma

Prediction of survival and immunotherapy response by the combined classifier of G protein-coupled receptors and tumor microenvironment in melanoma

Deep-learning-based survival prediction of patients with cutaneous malignant melanoma

Optimizing Skin Cancer Survival Prediction with Ensemble Techniques

[Construction and Validation of Prediction Models of Risk Factors for Early Death in Patients With Metastatic Melanoma]

A clinical decision support system learned from data to personalize treatment recommendations towards preventing breast cancer metastasis

Machine learning and mechanistic modeling for prediction of metastatic relapse in early-stage breast cancer

A Robust Personalized Classification Method for Breast Cancer Metastasis Prediction

Bioinformatic and Machine Learning Applications in Melanoma Risk Assessment and Prognosis: A Literature Review

Risk factors and predictive models for early death in patients with advanced melanoma: A population-based study

Comparison and Modification of Survival Predicting System for Breast Cancer Patients with Bone Metastases

A novel predictive model incorporating immune-related gene signatures for overall survival in melanoma patients